The observations of reduction of AF-related APD shortening and TASK-1 current upregulation under A293 therapy are in line with previous studies in cardiomyocytes isolated from AF patients (Schmidt et al., 2015, 2017). This evidence concerns the gene KCNK3 and atrial fibrillation.